XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash Flows From Operating Activities    
Net income (loss) $ (66,574) $ 40,325
Adjustments to reconcile net income to net cash provided by operating activities    
Net accretion of bond premium 5,501 5,039
Depreciation and amortization 3,318 2,618
Stock-based compensation expense 2,927 4,045
Net realized investment (gains) losses 77,628 (40,304)
Net cash flows from equity and trading investments 17,148 639
Deferred income tax benefit (19,229) 7,716
Changes in:    
Accrued investment income 697 574
Premiums receivable (19,176) (56,062)
Deferred policy acquisition costs (3,274) (8,767)
Reinsurance receivables (55,512) 8,558
Prepaid reinsurance premiums (4,956) (1,049)
Income taxes receivable (19,184) 5,913
Other assets (9,162) (18,706)
Losses and loss settlement expenses 55,935 29,183
Unearned premiums 25,639 47,062
Accrued expenses and other liabilities (2,098) 10,562
Deferred income taxes 4,184 0
Other, net 10,420 (1,070)
Cash from operating activities 70,806 (4,049)
Net cash provided by operating activities 4,232 36,276
Cash Flows From Investing Activities    
Proceeds from sale of available-for-sale investments 16,907 36,490
Proceeds from call and maturity of available-for-sale investments 159,709 111,824
Proceeds from sale of other investments 2,750 2,315
Purchase of investments Mortgage Loans (5,323) (10,723)
Purchase of investments available-for-sale (117,299) (44,400)
Purchase of other investments (3,577) (11,986)
Purchase of property and equipment (12,040) (20,920)
Net cash provided by investing activities 41,127 62,600
Cash Flows From Financing Activities    
Issuance of common stock (562) 1,645
Repurchase of common stock (2,741) (69)
Payment of cash dividends (16,516) (16,122)
Net cash used in financing activities (19,819) (14,546)
Net Change in Cash and Cash Equivalents 25,540 84,330
Cash and Cash Equivalents at Beginning of Period 120,722 64,454
Cash and Cash Equivalents at End of Period $ 146,262 $ 148,784